Tailored Genes and Vessl Therapeutics Partner to Bring Blood-Vessel Gene Therapy to Canadian Patients
Two lentiviral vectors have already been developed by Tailored Genes to support Vessl Therapeutics preclinical program. Next comes clinical-grade manufacturing […]
